Michael John Rivera Rivera

Michael John Rivera Rivera

Universidad de Puerto Rico- Bayamón - San Juan / Puerto Rico
Medical and Health Sciences / Biochemistry
AD Scientific Index ID: 4760329
University of Puerto Rico- Bayamón
person_outline Michael John Rivera Rivera's MOST POPULAR ARTICLES
1-) Characterization of a dual Rac/Cdc42 inhibitor MBQ-167 in metastatic cancer T Humphries-Bickley, L Castillo-Pichardo, E Hernandez-O’Farrill, ... Molecular cancer therapeutics 16 (5), 805-818, 2017 752017
2-) Targeting Cdc42 with the anticancer compound MBQ-167 inhibits cell polarity and growth in the budding yeast S. cerevisiae MJ Rivera-Robles, J Medina-Velázquez, GM Asencio-Torres, ... Small GTPases 11 (6), 430-440, 2020 72020
3-) Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical modelsA Torres-Sanchez, M Rivera-Robles, L Castillo-Pichardo, ...Frontiers in Oncology 13, 1152458, 202312023
4-) Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancerLE Velázquez-Vega, M Rivera-Robles, AO Sánchez-Álvarez, ...Translational Oncology 44, 101928, 202412024
5-) Abstract P6-21-14: Targeting Rac/Cdc42 in human epidermal growth factor receptor 2 (HER2)-positive breast cancerMJ Rivera-Robles, JI Medina-Vlazquez, LD Borrero-Garcia, ...Cancer Research 79 (4_Supplement), P6-21-14-P6-21-14, 201912019